Skip to main content
logo
GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,825.00
0.00 (0.00%)
At close: Sep 11, 2026

GeneBioTech Co. ,Ltd Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,6723,7892,8652,5911,523-484.4
Depreciation & Amortization
1,3441,3871,3681,3381,2861,244
Loss (Gain) From Sale of Assets
-11.360.15-122.26-20.6905.88
Asset Writedown & Restructuring Costs
---589.54--
Provision & Write-off of Bad Debts
75.14-58.53-96.12-27.8336.8331.96
Other Operating Activities
681.04490.2797.551,066284.17155.03
Change in Accounts Receivable
-1,187953.98-1,6622,464-3,955-3,602
Change in Inventory
1,7352,966-2,239650.04-1,806-3,390
Change in Accounts Payable
1,040308.34-193.85-336.71-813.243,088
Change in Unearned Revenue
------1.96
Change in Income Taxes
----15.88118.62136.36
Change in Other Net Operating Assets
-1,990-2,222-1,182-929.93-353.49103.98
Operating Cash Flow
5,3607,614-463.877,369-3,679-2,713
Operating Cash Flow Growth
80.45%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-834.9-3,758-1,100-530.02-1,155-3,102
Sale of Property, Plant & Equipment
74.911224.6223.14-6.36
Sale (Purchase) of Intangibles
-1.74-1.74-82.71-236.9-18.91-12.28
Investment in Securities
-6,768-3,733124.03-4,6081,6858,397
Other Investing Activities
46.3162.916.96-31.71-5.9211.41
Investing Cash Flow
-7,366-7,312-1,030-5,326649.965,745

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-15,64516,67312,39817,01514,232
Long-Term Debt Issued
-4,2401,8302,2001,3751,000
Total Debt Issued
16,72319,88518,50314,59818,39015,232
Short-Term Debt Repaid
--18,394-13,841-14,013-15,237-10,623
Long-Term Debt Repaid
--2,484-1,686-1,298-117.76-2,984
Total Debt Repaid
-15,392-20,878-15,527-15,311-15,355-13,608
Net Debt Issued (Repaid)
1,331-992.942,976-712.613,0351,625
Dividends Paid
-430.53-----258.32
Other Financing Activities
00-0--5,820
Financing Cash Flow
900.71-992.942,976-712.613,035-4,453

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
30.38-0.9546.92-9.59-657.42
Miscellaneous Cash Flow Adjustments
----0--
Net Cash Flow
-1,076-692.081,5291,321-0.08-1,364

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
4,5253,856-1,5646,838-4,834-5,816
Free Cash Flow Growth
------
Free Cash Flow Margin
5.07%4.25%-1.89%8.60%-5.84%-9.26%
Free Cash Flow Per Share
526.18447.87-181.81794.19-561.41-675.39
Levered Free Cash Flow
3,7432,937-3,0645,514-5,633-5,825
Unlevered Free Cash Flow
4,0793,289-2,6625,877-5,460-5,730

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
331.92557.89621.87177.07181.3936.97
Cash Income Tax Paid
622.2486.34418.01216.78-141.85386.84
Change in Working Capital
-401.272,007-5,2771,832-6,810-3,666